The current path to CAR-T cell therapy is, by any measure, a logistical ordeal. A patient’s immune cells must be drawn out of the body, shipped to a specialized facility, genetically reprogrammed, ...

TYK2 can act to suppress breast cancer, researchers say, and drugs that inhibit it can promote ‘breast cancer invasion and ...

Researchers at the University of Geneva have built a molecular system that can tell the difference between a cancer cell and ...

Cells aren’t as passive as scientists once thought—they actively create internal currents to move proteins quickly and ...

A technique that transforms immune cells into cancer-seeking bloodhounds may overcome a roadblock that has hampered ...

Chimeric antigen receptor T-cell therapy—CAR T for short—has been a major advance in treating blood cancers like leukemia and ...

For his work towards developing a novel cancer immunotherapy that turns tumors into their own vaccines, Fábio Rosa has ...

The FDA has delayed its target decision date for Orca Bio’s blood cancer cell therapy candidate Orca-T by three months to ...